Atrial Fibrillation |
Decreased MANF mRNA and protein in serum |
Wang et al 2019 |
Diabetes Type 1 |
Increased MANF protein in plasma |
Galli et al 2016
|
Diabetes Type 2 |
Increased MANF protein in plasma |
Wu et al 2017, Fu et al 2020
|
Fasting |
Increased MANF protein in plasma |
Galli et al 2019a
|
Hepatocellular carcinoma |
Increased MANF mRNA and protein in tissue |
He et al 2020a
|
Hyperlipidemia |
Increased MANF protein in serum |
Fu et al 2020
|
Nonalcoholic Steatohepatitis |
Decreased MANF protein in serum |
Sousa-Victor et al 2019
|
Parkinson’s disease |
Increased MANF protein in plasma |
Galli et al 2019b
|
Parkinson’s disease |
Increased CDNF protein in hippocampus |
Virachit et al 2019
|
Physiological ageing |
Decreased MANF protein in plasma |
Sousa-Victor et al 2019
|
Polycystic ovary syndrome |
Decreased MANF protein in plasma |
Wei et al 2020
|
Proliferative diabetic retinopathy |
Increased MANF protein in vitreous |
Gao et al 2017
|
Retinal detachment |
Increased MANF protein in vitreous |
Gao et al 2017
|
Rheumatoid arthritis |
Increased MANF mRNA in white blood cells |
Chen et al 2015
|
Stroke |
Decreased CDNF mRNA levels in blood platelets |
Joshi et al 2020
|
Systemic lupus erythematosus |
Increased MANF mRNA in white blood cells |
Chen et al 2015
|